V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20219807 | 20168957 | 0 | 85.6 | Palliative (P) | 2016-11-20 | 2016-12-22 | LENVATINIB | 02 | N | FLUOROURACIL + MITOMYCIN | 100044606 |
| 20219865 | 20168958 | 0 | null | null | 2019-08-28 | 2019-11-08 | null | 02 | null | LANREOTIDE | 100037819 |
| 20219889 | 20168959 | 1.52 | 86 | Palliative (P) | 2017-12-21 | 2018-01-13 | null | 02 | N | HCX | 100176802 |
| 20219892 | 20168960 | 0 | 52.7 | Palliative (P) | 2018-05-13 | 2018-05-17 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 101217790 |
| 20219912 | 20168962 | 0 | 0 | Palliative (P) | null | 2015-03-08 | null | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100171984 |
| 20219915 | 20168963 | 0 | null | null | null | 2020-03-11 | LANREOTIDE | 02 | null | LANREOTIDE | 100545448 |
| 20219926 | 20168964 | 0 | 81.1 | Palliative (P) | null | 2020-10-20 | LANREOTIDE | 02 | N | LANREOTIDE | 100647383 |
| 20219930 | 20168965 | 1.79 | null | Palliative (P) | 2016-08-16 | 2017-01-19 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101594380 |
| 20219948 | 20168966 | 0 | null | Palliative (P) | null | 2019-07-30 | null | N | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101108994 |
| 20219957 | 20168967 | 0 | 64.4 | Palliative (P) | 2020-08-10 | 2020-08-10 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101752256 |
| 20219975 | 20168968 | 0 | null | Curative (C) | null | 2019-03-16 | LANREOTIDE | N | Y | LANREOTIDE | 100179707 |
| 20219978 | 20168969 | 0 | 80.5 | null | 2016-11-23 | 2017-03-17 | null | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100119913 |
| 20219994 | 20168970 | 0 | null | Palliative (P) | 2018-07-16 | 2018-10-19 | null | 02 | N | CAPECITABINE + MITOMYCIN | 101056989 |
| 20220017 | 20168971 | 0 | null | null | 2017-09-05 | 2017-09-19 | LENVATINIB | 02 | null | LENVATINIB | 100612432 |
| 20220061 | 20168972 | 0 | null | null | 2019-01-11 | 2019-01-12 | Cape+Cisplatin+Trastuzumab Main | 02 | null | LANREOTIDE | 101638405 |
| 20220065 | 20168973 | 0 | 48.1 | null | 2017-08-11 | 2018-11-05 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + MITOMYCIN | 100503704 |
| 20220070 | 20168974 | 0 | 84.4 | Palliative (P) | null | 2020-09-20 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101607846 |
| 20220091 | 20168975 | 0 | 0 | Palliative (P) | null | 2021-07-10 | null | 02 | N | FLUOROURACIL + MITOMYCIN | 100566479 |
| 20220115 | 20168976 | 0 | null | null | 2019-10-01 | 2019-10-25 | null | 02 | null | HCX | 100125841 |
| 20220163 | 20168977 | 0 | 59.8 | null | 2018-01-03 | 2018-01-27 | OXALIPLATIN + MDG + PANITUMUMAB | null | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101768239 |
| 20220167 | 20168978 | 0 | 76.7 | null | 2021-09-15 | 2021-12-24 | null | 02 | null | HCX | 101793898 |
| 20220173 | 20168979 | 0 | 49.5 | null | 2017-02-05 | 2017-02-13 | LANREOTIDE | 02 | null | LANREOTIDE | 100927755 |
| 20220179 | 20168980 | 0 | 67.1 | null | 2016-08-17 | 2017-10-31 | null | 02 | null | CAPECITABINE + MITOMYCIN | 101150997 |
| 20220240 | 20168981 | 0 | null | Palliative (P) | null | 2019-11-18 | null | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100119118 |
| 20220299 | 20168983 | 0 | 68 | null | null | 2019-04-22 | null | 02 | null | HCX | 100788704 |
| 20220334 | 20168985 | 1.55 | 79 | null | 2016-12-12 | 2017-02-27 | null | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101443742 |
| 20220344 | 20168987 | 0 | 106.2 | Palliative (P) | 2016-09-22 | 2016-09-22 | LANREOTIDE | 02 | null | LANREOTIDE | 101285395 |
| 20220352 | 20168988 | 0 | 88.75 | null | 2017-08-19 | 2018-06-24 | LANREOTIDE | 02 | null | LANREOTIDE | 101225375 |
| 20220389 | 20168990 | 0 | 79.6 | null | 2017-08-11 | 2017-08-11 | null | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101684051 |
| 20220397 | 20168991 | 0 | 0 | Neo-adjuvant (N) | 2016-06-16 | 2016-06-27 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100387687 |
| 20220432 | 20168993 | 0 | null | null | 2018-07-30 | 2018-07-30 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101015966 |
| 20220434 | 20168994 | 0 | 81.6 | null | 2016-07-06 | 2016-07-09 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101205351 |
| 20220439 | 20168995 | 0 | 93 | null | 2019-06-27 | 2019-12-19 | LENVATINIB | 02 | null | LENVATINIB | 100568110 |
| 20220445 | 20168996 | 0 | null | 03 | 2021-03-10 | 2021-04-07 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100117428 |
| 20220451 | 20168997 | 0 | 73.5 | Palliative (P) | 2021-10-03 | 2021-11-30 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100162661 |
| 20220473 | 20168998 | 0 | null | Palliative (P) | null | 2019-09-03 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100533008 |
| 20220484 | 20168999 | 0 | null | null | 2019-11-01 | 2019-12-11 | null | 99 | Y | DOXORUBICIN EMBOLISATION | 100533095 |
| 20220493 | 20169000 | 0 | 0 | null | 2019-01-13 | 2019-06-24 | null | 02 | null | LENVATINIB | 101463349 |
| 20220495 | 20169001 | 0 | 85 | Curative (C) | 2019-03-13 | 2019-04-01 | LENVATINIB | 02 | N | LENVATINIB | 101388176 |
| 20220499 | 20169002 | 0 | 69.9 | Palliative (P) | 2019-12-22 | 2020-03-01 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100678516 |
| 20220516 | 20169003 | 0 | 84.2 | null | 2018-07-03 | 2018-07-15 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100975058 |
| 20220534 | 20169004 | 0 | null | Curative (C) | 2016-11-07 | 2016-12-16 | LANREOTIDE | 02 | N | LANREOTIDE | 100844930 |
| 20220578 | 20169005 | 0 | 69 | null | 2018-08-02 | 2019-01-28 | LANREOTIDE | 02 | null | LANREOTIDE | 101496190 |
| 20220591 | 20169006 | 0 | 59 | Palliative (P) | 2016-11-21 | 2016-11-28 | LANREOTIDE | 02 | N | LANREOTIDE | 101738612 |
| 20220597 | 20169007 | 0 | 95 | Palliative (P) | 2017-07-23 | 2017-07-23 | LANREOTIDE | 02 | null | LANREOTIDE | 100382892 |
| 20220604 | 20169008 | 0 | 68.75 | null | 2017-03-22 | 2017-04-09 | LANREOTIDE | 02 | null | LANREOTIDE | 100280549 |
| 20220624 | 20169009 | 0 | null | Palliative (P) | 2020-01-11 | 2020-01-11 | LANREOTIDE | 02 | N | LANREOTIDE | 100526319 |
| 20220673 | 20169010 | 0 | null | Palliative (P) | 2019-09-01 | 2019-10-13 | LANREOTIDE | 02 | N | LANREOTIDE | 100161004 |
| 20220684 | 20169011 | 0 | 99.1 | 03 | 2020-11-24 | 2020-11-29 | LANREOTIDE | 02 | N | LANREOTIDE | 101029107 |
| 20220689 | 20169012 | 1.63 | 74.9 | Curative (C) | 2016-02-08 | 2016-02-18 | LANREOTIDE | 02 | Y | LANREOTIDE | 100739337 |